Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actelion

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Actelion's 2013 sales performance.

Afinitor and Uptravi gain funding from NHS England

Afinitor and Uptravi gain funding from NHS England

Rare disease treatments navigate tricky market access route. Novartis’ Afinitor in Tuberous Sclerosis Complex (TSC)-related epilepsy patients and Actelion’s pulmonary arterial hypertension (PAH) treatment Uptravi (selexipag) have gained funding

Act on PAH: Improve Patient Outcomes with Early Diagnosis

by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications. ... Act on PAH: Improve Patient Outcomes with Early Diagnosis - by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications.

Act on PAH: Improve Patient Outcomes with Early Diagnosis

by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications. ... Act on PAH: Improve Patient Outcomes with Early Diagnosis - by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications.

HS Online

Act on PAH: Improve Patient Outcomes with Early Diagnosis - by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications.

IBD Registry Industry Working Group

Act on PAH: Improve Patient Outcomes with Early Diagnosis - by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics